Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.
about
Myocardial gene transfer: routes and devices for regulation of transgene expression by modulation of cellular permeabilityHeart failure management: the present and the future.The road ahead: working towards effective clinical translation of myocardial gene therapies.Cardiac gene therapy: optimization of gene delivery techniques in vivo.Surgical methods for cardiac gene transfer.Cardiac gene therapyMethods to improve cardiac gene therapy expression.Percutaneous transendocardial delivery of self-complementary adeno-associated virus 6 achieves global cardiac gene transfer in canines.Targeted high-efficiency, homogeneous myocardial gene transfer.MRI roadmap-guided transendocardial delivery of exon-skipping recombinant adeno-associated virus restores dystrophin expression in a canine model of Duchenne muscular dystrophy.The future of regenerative therapy in patients with chronic heart failure.Potential of gene therapy as a treatment for heart failureMyocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient ExpressionReal-time intraoperative assessment of the extrahepatic bile ducts in rats and pigs using invisible near-infrared fluorescent light.Gene therapy in the treatment of heart failure.Intraoperative detection of cell injury and cell death with an 800 nm near-infrared fluorescent annexin V derivative.Gene therapy for cardiac arrhythmias: a dream soon to come true?Current strategies for myocardial gene delivery.Gene therapy in heart failure.Designing heart performance by gene transfer.Targeting sarcoplasmic reticulum calcium ATPase by gene therapy.Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure.Targeted gene therapy for the treatment of heart failure.Adjuvant early and late cardioprotective therapy: access to the heart.Percutaneous methods of vector delivery in preclinical models.Gene therapy for heart failure: where do we stand?Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors.Percutaneous approaches for efficient cardiac gene delivery.Therapeutic potential of genes in cardiac repair.Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium.Cardiac gene therapy: are we there yet?Gene-therapy delivery strategies in cardiology.Treatment of heart failure by calcium cycling gene therapy.Three catheter-based strategies for cardiac delivery of therapeutic gelatin microspheres.Gene Therapy in Heart Failure.Cardiac Gene Delivery in Large Animal Models: Antegrade Techniques.Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals.
P2860
Q30440788-B05077D8-B8B4-490F-B115-2EDD2376C824Q33605156-16036EE8-49C3-49EB-ACDB-756284B2FAADQ33705144-06880D4F-A90B-4863-B25C-A4D7CC59B415Q33832137-C32ED166-AE04-49F7-8A30-532FDA140A58Q34082093-FF880071-41BE-4774-9F18-FEE02F371ADBQ34409721-7A5E6871-2E92-4BE8-9AED-6BC7B7A082B0Q35360600-9056DD4F-5ADB-456E-AF86-F18731B3F448Q35621815-89D7E27D-BE35-410A-A83E-C2E5DDB07A7FQ35990749-843BEF3E-869D-4B58-9F22-10E8F16CDED7Q36179776-CD6EAA8A-D631-438C-8615-22843232683EQ36406450-AFF10651-FEF0-4166-85D6-46EB9C7D4FBAQ36497159-D597A2F0-1451-4455-A5AE-239CFA711208Q36582843-284C586E-345F-4525-94F8-C3B2F5A00497Q36757097-4D8FB836-EA0A-4D93-B0A2-338803AB503BQ36786243-CD1DAE43-1E43-476F-9E77-38078DB8CAE7Q36793908-5629CECA-12FD-4B79-AA50-4ADA033B2DE6Q36800517-B0A747E3-3F51-4E5F-BA4E-D1B8D49ADBEBQ36931967-0A804430-42F2-412C-B526-E0BD6B7E7C8EQ36944623-64626ADB-617D-4A71-A0DB-D071D73D4D88Q37299072-65AC8505-26F3-4316-8059-AFC82C32374BQ37550406-CBC096DC-DCEA-4A24-B52C-8FB461531769Q37676218-5A67413E-2B20-4039-ACC0-935C40765ABEQ37878086-EAE8B5A1-5F6D-47A4-99E0-1FC3B8A31866Q37982681-30E7A9A1-E1BC-45AE-B2E4-ABE051740D07Q37993680-8FC7F938-A6E4-46C5-8FD8-7E399A1B023AQ38073152-4452A2EF-A898-469B-8DA1-AFB1B98EDAE1Q38081027-F08AE279-6DD8-4A7C-AD2F-870035D99E87Q38113171-3858A7A6-E8B5-4290-96F7-F558B8DDCDBCQ38128924-5C7136BC-1D40-482A-AC40-D93860F7E766Q38132253-1CC1824D-F06F-43D8-A2F6-43F265BEDAACQ38820937-0D44EE92-72EC-4659-B249-682FAEC3E404Q40119187-995A3DC9-7252-44D5-8ABE-A3FAD3BA8DF9Q40199219-AE4DD1CC-B98C-4935-8CBA-9DB00B902A86Q45858433-C70502D5-7C06-4B0A-908D-23DAD66A8661Q45861410-E541B2C7-666A-4B45-A7D5-9F3C0DC2DA86Q45862445-7CA111D1-F635-43BE-8675-1404F4B4EBA5Q45879221-827602F4-37A0-4EEE-9F02-F7B7E2723C5D
P2860
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.
@ast
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.
@en
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.
@nl
type
label
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.
@ast
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.
@en
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.
@nl
prefLabel
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.
@ast
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.
@en
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.
@nl
P2093
P2860
P1476
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.
@en
P2093
Alec M De Grand
Briain D Macneill
Federica Del Monte
Jennifer McGregor
Judith K Gwathmey
Kozo Hoshino
Motoya Hayase
Roger J Hajjar
Ryuichi Yoneyama
Tsuyoshi Tsuji
P2860
P304
H2995-3000
P356
10.1152/AJPHEART.00703.2004
P577
2005-06-01T00:00:00Z